Discover the full management transaction log of Chromocell Therapeutics Corp, a publicly traded company based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). The latest transaction was filed on 16 September 2024 (Acquisition). Among the most active insiders: Francis Knuettel II. Every trade is free.
7
Insider Decl.
0
Thresholds
€108,088
4 ops.
Buy Volume
·
0 ops.
Sell Volume
46Σ signal
Buys €108,088· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.